<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Spatial Contrast Sensitivity (CS) was studied in 20 patients with benign intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> (BIH) </plain></SENT>
<SENT sid="1" pm="."><plain>At presentation CS loss was found in 43% of the eyes, and impairment of visual acuity attributed to BIH in only 16% </plain></SENT>
<SENT sid="2" pm="."><plain>Nine patients had <z:hpo ids='HP_0000622'>blurred vision</z:hpo> or visual obscurations, <z:hpo ids='HP_0000001'>all</z:hpo> of whom had abnormal CS </plain></SENT>
<SENT sid="3" pm="."><plain>The clinical application of CS measurement in BIH for monitoring the progression or regression of the disease is illustrated by serial measurements in 11 patients </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000529'>Progressive visual loss</z:hpo> in longstanding <z:e sem="disease" ids="C0030353" disease_type="Disease or Syndrome" abbrv="">papilloedema</z:e> and improvement of visual function in subsiding <z:e sem="disease" ids="C0030353" disease_type="Disease or Syndrome" abbrv="">papilloedema</z:e> can occur without any change in Snellen acuity or visual field charting </plain></SENT>
</text></document>